Westfield Capital Management Company »

Xenon Pharmaceuticals shares owned by Westfield Capital Management Company

Quarter-by-quarter ownership of Xenon Pharmaceuticals (XENE) shares owned by Westfield Capital Management Company from 13F filings

Historical chart of Westfield Capital Management Company investment in Xenon Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Xenon Pharmaceuticals held by Westfield Capital Management Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Xenon Pharmaceuticals by Westfield Capital Management Company

Quarter filed Position value Share count Share price at filing
2023-12-31 $11M 238k 46.06

More positions owned by Westfield Capital Management Company

Microsoft Corporation (MSFT)
Ascendis Pharma A/s Sponsored Adr (ASND)
Apple (AAPL)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
TransDigm Group Incorporated (TDG)
NVIDIA Corporation (NVDA)
Visa Com Cl A (V)
Meta Platforms Cl A (META)
Builders FirstSource (BLDR)
Dex (DXCM)
UnitedHealth (UNH)
Servicenow (NOW)
Axon Enterprise (AXON)
Saia (SAIA)

View all positions for Westfield Capital Management Company

Top funds holding Xenon Pharmaceuticals

venBio Select Advisor
Wellington Management Company
Commodore Capital
Paradigm Biocapital Advisors
Braidwell
First Light Asset Management
Alliancebernstein
Marshall Wace
Citadel Advisors
Perceptive Advisors
Baker Bros. Advisors
Henderson Group
BVF
Point72 Asset Management
Avidity Partners Management

View all funds holding Xenon Pharmaceuticals